1. Home
  2. VERA vs RNST Comparison

VERA vs RNST Comparison

Compare VERA & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • RNST
  • Stock Information
  • Founded
  • VERA 2016
  • RNST 1904
  • Country
  • VERA United States
  • RNST United States
  • Employees
  • VERA N/A
  • RNST N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • RNST Major Banks
  • Sector
  • VERA Health Care
  • RNST Finance
  • Exchange
  • VERA Nasdaq
  • RNST Nasdaq
  • Market Cap
  • VERA 2.5B
  • RNST 1.8B
  • IPO Year
  • VERA 2021
  • RNST N/A
  • Fundamental
  • Price
  • VERA $42.01
  • RNST $34.78
  • Analyst Decision
  • VERA Strong Buy
  • RNST Buy
  • Analyst Count
  • VERA 9
  • RNST 5
  • Target Price
  • VERA $53.56
  • RNST $39.50
  • AVG Volume (30 Days)
  • VERA 683.6K
  • RNST 408.3K
  • Earning Date
  • VERA 11-07-2024
  • RNST 10-22-2024
  • Dividend Yield
  • VERA N/A
  • RNST 2.55%
  • EPS Growth
  • VERA N/A
  • RNST 6.88
  • EPS
  • VERA N/A
  • RNST 3.09
  • Revenue
  • VERA N/A
  • RNST $685,818,000.00
  • Revenue This Year
  • VERA N/A
  • RNST N/A
  • Revenue Next Year
  • VERA N/A
  • RNST $35.64
  • P/E Ratio
  • VERA N/A
  • RNST $11.16
  • Revenue Growth
  • VERA N/A
  • RNST 8.35
  • 52 Week Low
  • VERA $9.68
  • RNST $24.02
  • 52 Week High
  • VERA $50.78
  • RNST $37.40
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.57
  • RNST 62.45
  • Support Level
  • VERA $39.22
  • RNST $31.08
  • Resistance Level
  • VERA $50.00
  • RNST $34.89
  • Average True Range (ATR)
  • VERA 2.41
  • RNST 0.90
  • MACD
  • VERA 0.24
  • RNST 0.23
  • Stochastic Oscillator
  • VERA 28.53
  • RNST 99.23

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation operates in the southern United States.

Share on Social Networks: